GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis Sep 25, 2024 21:00 HKT/SGT Read More
China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China Sep 24, 2024 22:00 JST Read More
DEXIS Digital Ecosystem Expands With Three New Innovations To Streamline and Connect Dental Workflows Sep 24, 2024 21:30 HKT/SGT Read More
China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China Sep 24, 2024 21:00 HKT/SGT Read More
Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management Sep 17, 2024 20:30 HKT/SGT Read More
Cordlife Unveils Enhanced Processing and Storage Facility in Singapore; Strengthens Processes as It Resumes Collection of Cord Blood Units in a Controlled Manner Sep 17, 2024 13:30 HKT/SGT Read More
Femto Technologies Regains Compliance With Nasdaq Minimum Bid Price Requirement Sep 12, 2024 21:00 HKT/SGT Read More
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies, Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801) Sep 11, 2024 12:00 HKT/SGT Read More
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies, Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801) Sep 11, 2024 11:34 HKT/SGT Read More